Cargando…

Potential Applications of Plant Biotechnology against SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus responsible for an ongoing human pandemic (COVID-19). There is a massive international effort underway to develop diagnostic reagents, vaccines, and antiviral drugs in a bid to slow down the spread of the disease and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capell, Teresa, Twyman, Richard M., Armario-Najera, Victoria, Ma, Julian K.-C., Schillberg, Stefan, Christou, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Opinion
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181989/ https://www.ncbi.nlm.nih.gov/pubmed/32371057 http://dx.doi.org/10.1016/j.tplants.2020.04.009

Ejemplares similares

Production of the SARS‐CoV‐2 receptor‐binding domain in stably transformed rice plants for developing country applications
por: Saba‐Mayoral, Andrea, et al.
Publicado: (2023)

Synergistic antiviral effects against SARS-CoV-2 by plant-based molecules
por: Prasad, Ashish, et al.
Publicado: (2020)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

The importance of naturally attenuated SARS‐CoV‐2in the fight against COVID‐19
por: Armengaud, Jean, et al.
Publicado: (2020)

The emerging role of auxins as bacterial signal molecules: Potential biotechnological applications
por: Krell, Tino, et al.
Publicado: (2023)

SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity
por: Mullbacher, Arno, et al.
Publicado: (2020)

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2
por: Muñoz-Basagoiti, Jordana, et al.
Publicado: (2023)

Agricultural biotechnology for sustainable food security
por: Tyczewska, Agata, et al.
Publicado: (2023)

T Cells: Warriors of SARS-CoV-2 Infection
por: de Candia, Paola, et al.
Publicado: (2021)

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2
por: Bauer, Lisa, et al.
Publicado: (2022)

Understanding Laboratory Testing for SARS-CoV-2
por: Cheema, Ritu, et al.
Publicado: (2021)

Rapid deployment of SARS-CoV-2 testing: The CLIAHUB
por: Crawford, Emily D., et al.
Publicado: (2020)

The paradigm of immune escape by SARS-CoV-2 variants and strategies for repositioning subverted mAbs against escaped VOCs
por: Shah, Masaud, et al.
Publicado: (2022)

AI, big data, and robots for the evolution of biotechnology
por: Kim, Haseong
Publicado: (2019)

Nano-targeting lessons from the SARS-CoV-2
por: Ribeiro, I.R.S., et al.
Publicado: (2021)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19
por: De Angelis, Maria Laura, et al.
Publicado: (2021)

SARS-CoV-2–A Tough Opponent for the Immune System
por: Nasab, Mahsa Golshani, et al.
Publicado: (2020)

Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2?
por: Tournier, Jean-Nicolas, et al.
Publicado: (2021)

Are Older People Really More Susceptible to SARS-CoV-2?
por: Zhang, Shuo, et al.
Publicado: (2022)

Heme, Heme Oxygenase-1, Statins, and SARS-CoV-2
por: Stevenson, David K., et al.
Publicado: (2023)

Spying on SARS-CoV-2 with Fluorescent Tags and Protease Reporters
por: To, Tsz-Leung, et al.
Publicado: (2023)

Plastic waste as a novel substrate for industrial biotechnology
por: Wierckx, Nick, et al.
Publicado: (2015)

Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1
por: Armario-Najera, Victoria, et al.
Publicado: (2022)

Can We Protect Those We Care for in A Pandemic? - Prevalence of Neutralizing Antibodies against SARS-CoV-2 in Nursing Homes
por: Willschke, Harald, et al.
Publicado: (2021)

Patterns of CRISPR/Cas9 activity in plants, animals and microbes
por: Bortesi, Luisa, et al.
Publicado: (2016)

SARS-CoV-2 and the next generations: which impact on reproductive tissues?
por: Zupin, Luisa, et al.
Publicado: (2020)

SARS-CoV-2: Cross-scale Insights from Ecology and Evolution
por: Snedden, Celine E., et al.
Publicado: (2021)

Why Does SARS-CoV-2 Infection Induce Autoantibody Production?
por: Macela, Ales, et al.
Publicado: (2021)

The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2
por: Sarkar, Amar, et al.
Publicado: (2021)

The Safety of Anti-SARS-CoV-2 Vaccines: Vigilance Is Still Required
por: Goldman, Michel
Publicado: (2022)

Targeting SARS-CoV-2 papain-like protease in the postvaccine era
por: Ton, Anh-Tien, et al.
Publicado: (2022)

Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines
por: Fraser, Rupsha, et al.
Publicado: (2023)

Biotechnology for Tomorrow’s World: Scenarios to Guide Directions for Future Innovation
por: Cornelissen, Marc, et al.
Publicado: (2021)

Is Sexual Route a Matter of Concern for the SARS-CoV-2/COVID-19?
por: Patel, Shailesh Kumar, et al.
Publicado: (2020)

SARS-CoV-2 another kind of liver aggressor, how does it do that?
por: Lozano-Sepulveda, Sonia A., et al.
Publicado: (2020)

Cautionary note on contamination of reagents used for molecular detection of SARS-CoV-2
por: Huggett, Jim F, et al.
Publicado: (2020)

Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time
por: Czajka, Timothy F., et al.
Publicado: (2021)

SARS-CoV-2 Emergency and Long-Term Cognitive Impairment in Older People
por: Rizzo, Maria Rosaria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m82nfdl10arts9bsmc1lucka2s